Home
BakerHostetler
Nita Garg
Nita Garg
BakerHostetler
Vermont To Require Drug Transparency
23 Jun 2016 | United States
HHS Reopens Comment Period For Proposed Rule On 340B Drug Program
27 Apr 2016 | United States
New Medicare Part B Payment Model Is Most Recent Payor Response To Increasing Drug Prices
14 Apr 2016 | United States
CMS Pitches Controversial Payment Model For Medicare Part B Drugs
04 Apr 2016 | United States
Increased Scrutiny Of Drug Pricing – What Should Pharmaceutical Companies Know
05 Feb 2016 | United States
House Passes Bill To Help Prevent Prescription Drug Abuse
16 Oct 2015 | United States
340B Guidance: Eight Key Points Covered Entities Should Consider
16 Sep 2015 | United States
How Far Is Too Far? Court Rules For Amarin In Off-Label Marketing Fight Against FDA
18 Aug 2015 | United States
House Passes 21st Century Cures Act
21 Jul 2015 | United States
Health Law Update – July 16, 2015
20 Jul 2015 | United States
21st Century Cures Act Passes House Committee
08 Jun 2015 | United States
Otsuka Suit Results In Victory For FDA
05 Jun 2015 | United States
Amarin Pharma Sues FDA Over Constitutional Right To Discuss Off-Label Uses
15 May 2015 | United States
New Data On Part D Prescription Drugs Available
12 May 2015 | United States
FDA Finalizes Guidance Documents On Biosimilars
12 May 2015 | United States
OIG Provides Additional Compliance Guidance For Healthcare Governing Boards
28 Apr 2015 | United States
FDA Establishes Docket For Public Comments On Drug Compounding
23 Mar 2015 | United States
Medicare Advantage And Medicare Part D Changes For 2016 Released
06 Mar 2015 | United States
FDA Guidance Documents Change Compounding Landscape
06 Mar 2015 | United States
Seventh Circuit Upholds Physician’s Conviction For Violation Of The Anti-Kickback Law Based On Expansive Definition Of "Referral"
05 Mar 2015 | United States
< 1 2 >
Contact Details
Houston
Houston
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.